1. PRLog Home
  2. Business Index
  3. Pressroom Index
  4. Press Releases Home
  1. Press Room
  2. Contact
Filter By Industry
Filter By Tag

Press Room

www.martincwiner.com Press releases

1 - 9 of 9 Press Releases

Nov 09, 2012
“Why are donated funds being used to fund advertisements against DCA?” Clearly those funds would be better directed towards research? Why single out DCA? There are literally hundreds of agents which have shown promise but are not patentable.

Nov 07, 2012
DCA in conjunction with radiation led to a long term (5 year) remission in a cancer (Renal squamous cell carcinoma (“RSCC”)) which was previously considered untreatable and incurable in the field.

Jun 15, 2012
As a follow up to a previous reports of DCA and Avemar working against AML Leukemia and CLL Leukemia, a new case has surfaced of the protocol working against Hormone Resistant Prostate Cancer.

Jun 08, 2012
DCA and Avemar, two non-chemotherapy products in combination have shown dramatic effects against both AML and CLL Leukemia.

May 25, 2012
A protocol for treating cancer using DCA (Dichloroacetate) and Avemar (a cancer fighting nutritional supplement) has shown clinical promise in treating the particularly pernicious AML Leukemia.

May 05, 2012
The mainstream media has given rather cursory coverage of the last penny to be minted by the Royal Canadian Mint. Could this be the fore-bearer of hyperinflation to come?

May 03, 2012
Cancer is not a medical problem; it is a human problem. Ever since the war on cancer was unleashed in 1971, very little progress has been made in the fight because the research system is itself suffering from cancer.

Apr 30, 2012
Telehealth Ontario is a useless service that costs taxpayers more money than it saves them. Asking a registered nurse to perform a triage of a patient over a standard phone line without being able to examine them is sheer lunacy.

Apr 27, 2012
Many promising treatments are going unresearched because they cannot be patented. An alteration of an existing piece of US legislation: "The Orphan Drug Act" may allow pharmeceutical companies to profit from this research and hence show interest.



RSS Feed for www.martincwiner.com Press Releases